"Ethinyl Estradiol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.
| Descriptor ID |
D004997
|
| MeSH Number(s) |
D04.210.500.668.651.568.291 D06.472.334.851.437.968.500
|
| Concept/Terms |
Ethinyl Estradiol- Ethinyl Estradiol
- Estradiol, Ethinyl
- Ethinyloestradiol
- Ethynyl Estradiol
- Estradiol, Ethynyl
|
Below are MeSH descriptors whose meaning is more general than "Ethinyl Estradiol".
Below are MeSH descriptors whose meaning is more specific than "Ethinyl Estradiol".
This graph shows the total number of publications written about "Ethinyl Estradiol" by people in this website by year, and whether "Ethinyl Estradiol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ethinyl Estradiol" by people in Profiles.
-
Orlin A, Orlin SE, Makar GA, Bunya VY. Presumed corneal copper deposition and oral contraceptive use. Cornea. 2010 Apr; 29(4):476-8.
-
Barmat LI, Chantilis SJ, Hurst BS, Dickey RP. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil Steril. 2005 Feb; 83(2):321-30.
-
Hendrix CW, Jackson KA, Whitmore E, Guidos A, Kretzer R, Liss CM, Shah LP, Khoo KC, McLane J, Trapnell CB. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone. Clin Pharmacol Ther. 2004 May; 75(5):464-75.
-
Schlaff WD, Lynch AM, Hughes HD, Cedars MI, Smith DL. Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression. Am J Obstet Gynecol. 2004 Apr; 190(4):943-51.
-
DeCherney A. Bone-sparing properties of oral contraceptives. Am J Obstet Gynecol. 1996 Jan; 174(1 Pt 1):15-20.
-
Corson SL. Efficacy and clinical profile of a new oral contraceptive containing norgestimate. U.S. clinical trials. Acta Obstet Gynecol Scand Suppl. 1990; 152:25-31.